Lunit opens European unit to hasten expansion

Lunit opens European unit to hasten expansion

South Korean medical AI company Lunit has announced its decision to establish a wholly-owned subsidiary in Europe.According to a press release, Lunit Europe Holdings will be based in Amsterdam in the Netherlands and will begin local staff recruitment shortly. 
WHY IT MATTERS
Although Lunit had a branch office which previously managed its European business, its subsidiary in the continent will allow it to plan for the expansion of its sales network and fortify existing partnerships there. 
According to data from Statista, the European medical device market is expected to be worth $136 billion this year. Its biggest segment is cardiology devices with a projected…

Continue Reading
Monday Morning Update 2/20/23

Monday Morning Update 2/20/23

Top News

The VA postpones its planned July 2023 Oracle Cerner go-live at its Ann Arbor, MI facilities until later this year or early in 2024.
The service region is concerned about “how well EHRM would interact with VA Ann Arbor’s vital medical research mission.”

Reader Comments From AT: “Re: pet peeves with service industry words and phrases. ‘I appreciate you,’ following my thanking you and leaving you a tip, which suggests that we are like-minded, decent people even though you have no way of knowing that. Second is thanking someone with ‘of course,” implying that I’m either too stupid to know…

Continue Reading
Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

Why Federally Mandated Electronic Prescribing for Controlled Substances will Benefit Public Health

Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…

Continue Reading
Bonus Features – February 19, 2023 – 80% of orgs collect SDOH data but struggle to make use of it, 2 in 3 cybersecurity pros say their orgs underestimate threats, and more

Bonus Features – February 19, 2023 – 80% of orgs collect SDOH data but struggle to make use of it, 2 in 3 cybersecurity pros say their orgs underestimate threats, and more

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
Surveys
A survey of 2,600 AHIMA members found that about 80% of healthcare organizations are collecting social determinants of health data. The bad news: Organizations face multiple challenges…

Continue Reading
What Will Value-Based Drug Pricing Look Like By 2030? Experts Share 4 Predictions

What Will Value-Based Drug Pricing Look Like By 2030? Experts Share 4 Predictions

Editor’s note: This story is based on discussions at Abarca Forward, a conference in San Juan, Puerto Rico, hosted by Abarca, a pharmacy benefit manager. MedCity News’ Editor-in-Chief Arundhati Parmar and Senior Reporter Katie Adams were invited to attend and speak at the conference. All travel and related expenses for the team were covered by Abarca. However, company officials had no input in editorial coverage. 
The U.S. healthcare systems spent a whopping $301 billion on specialty drugs in 2021, a 43% increase since 2016. These specialty drugs accounted for half of the year’s total drug spending, and the list prices for specialty…

Continue Reading